Tolkach Y - Search Results

1

Comprehensive Evaluation of Prostate Specific Membrane Antigen Expression in the Vasculature of Renal Tumors: Implications for Imaging Studies and Prognostic Role.

Spatz S, Tolkach Y, Jung K, Stephan C, Busch J, Ralla B, Rabien A, Feldmann G, Brossart P, Bundschuh RA, Ahmadzadehfar H, Essler M, Toma M, Müller SC, Ellinger J, Hauser S, Kristiansen G. Spatz S, et al. Among authors: tolkach y. J Urol. 2018 Feb;199(2):370-377. doi: 10.1016/j.juro.2017.08.079. Epub 2017 Aug 19. J Urol. 2018. PMID: 28827104

2

Initial experiences with the Hemopatch® as a hemostatic agent in zero-ischemia partial nephrectomy.

Imkamp F, Tolkach Y, Wolters M, Jutzi S, Kramer M, Herrmann T. Imkamp F, et al. Among authors: tolkach y. World J Urol. 2015 Oct;33(10):1527-34. doi: 10.1007/s00345-014-1404-4. Epub 2014 Sep 20. World J Urol. 2015. PMID: 25239500

3

Clinically relevant genetic characterization of prostate tumors: how close are we to the goal?

Tolkach Y, Imkamp F, Godin K, Van Poppel H. Tolkach Y, et al. Korean J Urol. 2015 Feb;56(2):90-8. doi: 10.4111/kju.2015.56.2.90. Epub 2015 Jan 30. Korean J Urol. 2015. PMID: 25685295 Free PMC article. Review.

4

Systematic expression analysis of the mitochondrial complex III subunits identifies UQCRC1 as biomarker in clear cell renal cell carcinoma.

Ellinger J, Gromes A, Poss M, Brüggemann M, Schmidt D, Ellinger N, Tolkach Y, Dietrich D, Kristiansen G, Müller SC. Ellinger J, et al. Among authors: tolkach y. Oncotarget. 2016 Dec 27;7(52):86490-86499. doi: 10.18632/oncotarget.13275. Oncotarget. 2016. PMID: 27845902 Free PMC article.

5

PITX2 DNA Methylation as Biomarker for Individualized Risk Assessment of Prostate Cancer in Core Biopsies.

Uhl B, Gevensleben H, Tolkach Y, Sailer V, Majores M, Jung M, Meller S, Stein J, Ellinger J, Dietrich D, Kristiansen G. Uhl B, et al. Among authors: tolkach y. J Mol Diagn. 2017 Jan;19(1):107-114. doi: 10.1016/j.jmoldx.2016.08.008. Epub 2016 Dec 8. J Mol Diagn. 2017. PMID: 27939865 Free article.

6

[Pathogenesis of urological complications after radiation therapy].

Tolkach Y, Kristiansen G. Tolkach Y, et al. Urologe A. 2017 Mar;56(3):293-300. doi: 10.1007/s00120-016-0292-1. Urologe A. 2017. PMID: 28005154 Review. German.

7

Systematic Expression Analysis of Mitochondrial Complex I Identifies NDUFS1 as a Biomarker in Clear-Cell Renal-Cell Carcinoma.

Ellinger J, Poss M, Brüggemann M, Gromes A, Schmidt D, Ellinger N, Tolkach Y, Dietrich D, Kristiansen G, Müller SC. Ellinger J, et al. Among authors: tolkach y. Clin Genitourin Cancer. 2017 Aug;15(4):e551-e562. doi: 10.1016/j.clgc.2016.11.010. Epub 2016 Dec 1. Clin Genitourin Cancer. 2017. PMID: 28063846

8

Adipophilin as prognostic biomarker in clear cell renal cell carcinoma.

Tolkach Y, Lüders C, Meller S, Jung K, Stephan C, Kristiansen G. Tolkach Y, et al. Oncotarget. 2017 Apr 25;8(17):28672-28682. doi: 10.18632/oncotarget.15639. Oncotarget. 2017. PMID: 28404922 Free PMC article.

9

Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMA.

Kristiansen I, Stephan C, Jung K, Dietel M, Rieger A, Tolkach Y, Kristiansen G. Kristiansen I, et al. Among authors: tolkach y. Int J Mol Sci. 2017 May 29;18(6):1151. doi: 10.3390/ijms18061151. Int J Mol Sci. 2017. PMID: 28555048 Free PMC article.

10

[Molecular biomarkers and prognostic factors for prostate cancer].

Kretschmer A, Tolkach Y, Ellinger J, Kristiansen G. Kretschmer A, et al. Among authors: tolkach y. Urologe A. 2017 Jul;56(7):933-944. doi: 10.1007/s00120-017-0418-0. Urologe A. 2017. PMID: 28573413 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters